A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer

Radiotherapy and Oncology

Volumn 98, Issue 3, 2011, Pages 304-308

  Zhu, Zheng Fei ^a,b   Fan, Min ^a,b   Wu, Kai Liang ^a,b   Zhao, Kuai Le ^a,b   Yang, Huan Jun ^a,b   Chen, Gui Yuan ^a,b   Jiang, Guo Liang ^a,b   Wang, Li Juan ^a,b   Zhao, Sen ^a,b   Fu, Xiao Long ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Accelerated radiotherapy; Hypofractionation; Non small cell lung cancer

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; LUNG NON SMALL CELL CANCER; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 79952438810     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.01.022     Document Type: Article

References (28)

1. National Institute for Health and Clinical Excellence. Lung Cancer: the diagnosis and treatment of lung cancer. Clinical Guideline 24. London: National Institute for Health and Clinical Excellence (NICE); 2005.
2. L. Robinson, J. Ruckdeschel, and H. Wagner Jr. Treatment of non-small cell lung cancer - stage IIIA: ACCP evidence-based guidelines (2nd ed.) Chest 132 2007 243S 265S (Pubitemid 47502811)
3. J.R. Jett, S. Schild, and R. Keith Treatment of non-small cell lung cancer - stage IIIB: ACCP evidenced-based clinical practice guidelines Chest 132 2007 266S 276S (Pubitemid 47502812)
4. J. Jassem The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol 83 2007 203 213 (Pubitemid 46776921)
5. F.R. Macbeth, R.P. Abratt, and K.H. Cho Lung cancer management in limited resource settings: guidelines for appropriate good care Radiother Oncol 82 2007 123 131 (Pubitemid 46275136)
6. S. Senan, D. De Ruysscher, and P. Giraud Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother Oncol 71 2004 139 146 (Pubitemid 38521181)
7. K.L. Wu, G.L. Jiang, and Y. Liao Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial Int J Radiat Oncol Biol Phys 57 2003 1336 1344 (Pubitemid 37443974)
8. S. Senan, S. Burgers, and M.J. Samson Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved field radiotherapy Int J Radiat Oncol Biol Phys 54 2002 999 1006 (Pubitemid 35299439)
9. K.E. Rosenzweig, S.E. Sim, and B. Mychalczak Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 50 2001 681 685 (Pubitemid 32519597)
10. J.F. Fowler, and R. Chappell Non-small cell lung tumors repopulate rapidly during radiation therapy Int J Radiat Oncol Biol Phys 46 2000 516 517 (Pubitemid 30067805)
11. M. Mehta, R. Scrimger, and T.R. Mackie A new approach to dose escalation in non-small cell lung cancer Int J Radiat Oncol Biol Phys 49 2001 23 33 (Pubitemid 32041273)
12. W.J. Curran, C.B. Scott, and C.J. Langer Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 2003 (abstr 2499)
13. P. Zatloukal, L. Petruzelka, and M. Zemanova Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study Lung cancer 46 2004 87 98 (Pubitemid 39201387)
14. P. Fournel, G. Robinet, and P. Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study J Clin Oncol 23 2005 5910 5917
15. F.B. Geara, R. Komaki, and S.L. Tucker Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation Int J Radiat Oncol Biol Phys 41 1998 279 286 (Pubitemid 28243538)
16. J.S. Belderbos, W.D. Heemsbergen, and K. De Jaeger Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134 (Pubitemid 44175671)
17. L. Kepka, D. Tyc-Szczepaniak, and K. Bujko Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer J Thorac Oncol 4 2009 853 861
18. P. Thirion, O. Holmberg, and C.D. Collins Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy Radiother Oncol 71 2004 163 166 (Pubitemid 38521184)
19. K. Matsuura, T. Kimura, and K. Kashiwado Results of a preliminary study using hypofractionated involved field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer Int J Clin Oncol 14 2009 408 415
20. R.O. Dillman, J. Herndon, and S.L. Seagren Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215 (Pubitemid 26302034)
21. W. Sause, P. Kolesar, and Taylor.S. IV Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364 (Pubitemid 30111583)
22. C. Schaake-Koning, W. van den Bogaert, and O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
23. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
24. J.D. Bradley, J. Moughan, and M.V. Graham A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117 Int J Radiat Oncol Biol Phys 77 2010 367 372
25. J. Belderbos, L. Uitterhoeve, and N. van Zandwijk Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) Eur J Cancer 43 2007 114 121 (Pubitemid 46054477)
26. D.G. Pfister, D.H. Johnson, and C.G. Azzoli American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353 (Pubitemid 41095099)
27. N. Hanna, M. Neubauer, and C. Yiannoutsos Phase III study of cisplatin, etoposide and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 2008 5755 5760
28. M. Moreno-Jiménez, J. Aristu, and J.M. López-Picazo Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation Radiother Oncol 88 2008 342 350